Closed · W81XWH-09-BCRP-MTA · CFDA 12.420 · Discretionary

DoD Breast Cancer Multi-Team Award

Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.

Varies
Award range
Closed
Status
June 17, 2009
Close date
3
Expected awards

The verdict

DoD Breast Cancer Multi-Team Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 3 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.

Varies
award range
Closed
application status
3
expected awards
12.420
CFDA program

Archived opportunity record

DoD Breast Cancer Multi-Team Award is closed (last close June 17, 2009). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed June 17, 2009

Posted Jan 24 Closes Jun 17

Est. Total Funding

$23,000,000

Expected Awards

3

Instrument

Grant

Description

The BCRP Multi-Team Award mechanism is a new award for FY09. The Multi-Team Award supports the creation of a collaborative research project among three teams, each led by a Principal Investigator (PI) with a history of creativity and innovation, to focus on a critical area of breast cancer. The Multi-Team Award should create an environment that fosters and supports innovation and creativity, with consistent, intensive interaction across teams in a way that engages all members of the teams in all aspects of the research project. The multi-team approach is expected to transform the research process through the integration of basic and clinical disciplines, substantive cross-disciplinary training among the team members, and integral participation of consumer advocates. The requirements for this award are as follows: Research Question: Research proposed under the Multi-Team Award must focus on a question of significant importance to breast cancer that has been inadequately addressed, or for which there may be an absence of an established paradigm or technical framework. The research question should address overarching issues that have broad implications for the disease and risk management (e.g., risk factors, dormancy) and not focus merely on the study of specific pathways or genes. Clinical research or a clinical trial (Phase 0, I, I/II, or II) must be included as part of the proposed work. PIs and Teams: The Multi-Team Award PIs must include at least one basic scientist, one clinician, and one additional individual from an appropriate area of expertise (e.g., epidemiology). At least two different institutions must be involved. Each of the three PIs is expected to have a track record of innovation and creativity and be well qualified to lead his/her respective team in this intensive collaboration. The collaborating PIs should work together to develop the research plan, determine the management structure, and prepare the application. It should be clear that all PIs have an equal level of intellectual input into the proposed project. Collectively, the members of the teams should represent the appropriate diversity of expertise necessary for addressing the research question. Effort is expected to be balanced among the three PIs and their teams, unless otherwise justified. Consumer Advocates: Each PI’s team must include one or more breast cancer consumer advocates who will be integrally involved throughout the planning and implementation of the research project and management of the collaboration. Consumer advocates should be involved in the identification of the research question, project design, oversight, recruitment, and evaluation, in addition to other areas. The consumer advocates must be individuals who have been diagnosed with breast cancer, and they should have a high level of training and familiarity with current issues in breast cancer research. Team Interaction and Training: Regular in-person meetings and cross-training among members of all three teams are requirements of this award. The in-person multi-team meetings are intended to assess research progress, address problems, and define future directions. These meetings must take place at least twice a year and must be attended by all three PIs, key research team members, and consumer advocates. It is also expected that frequent (e.g., weekly) meetings of all team members will occur using phone conference/webcast communications technology to share data and monitor progress toward specific aims. A server should be established that makes team member presentations and source data available to all team members. To provide immersive training and interaction across disciplines, at least two key members of each research team must dedicate time to working on the funded research in another collaborating team’s laboratory or clinic. This cross-training may be accomplished through one extensive visit of several weeks or through several separate visits. The PIs must present a clear plan for how they would manage and facilitate meaningful collaboration among the separate research teams to enable successful completion of the proposed research. Participating institutions must be willing to resolve potential intellectual and material property issues and remove institutional barriers to achieving high levels of cooperation. The proposal should include an organizational chart identifying the roles of all team members and the workflow within and between labs. The required Statement of Work (SOW) should indicate specific milestones and how specific aims toward these milestones will be staged or integrated. Key decision points in the organizational/work flow chart and SOW should be clearly defined and their impact on the overall project should be clear

Catch-all / unrestricted eligibility mark · W81XWH-09-BCRP-MTA

Grants.gov marks DoD Breast Cancer Multi-Team Award with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).

Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org

What to do next

DoD Breast Cancer Multi-Team Award is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants